Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import to Russia (July 2017)

Thursday, August 17, 2017

Between January and July 2017, Russia imported 329.6 bln RUB worth of pharmaceutical drugs (free circulation prices, VAT included.) Ready-made drugs account for 281.2 bln RUB, with an 8.1% increase. The in-bulk import has fallen by 24.2% (48.4 bln RUB). The total import has risen by only 1.8%.

In July, the import followed the season’s trends, with a 3.8% and 20.6% decline in the import of ready-made and in-bulk drugs, respectively.

In physical terms, the import of ready-made drugs has increased by 6.8%, with 1.1 bln units. However, if calculated in minimum dosage units (MDU), the import of ready-made drugs in physical terms has fallen by 4.1%, with 20.1 bln MDUs. The in-bulk import has risen by 5.5% in physical terms, with 2.4 bln MDUs. The total import has fallen by 3.1%, though.

Most pharmaceutical drugs, imported to Russia between January and July 2017, were manufactured in Germany (22% of the import in monetary terms). Russia imported from 68 countries, with Turkey having made the best progress by doubling its import (0.6% of the import). The Netherlands and Switzerland have shown the worst dynamics, with a 22% and 21% decrease, respectively.

Read more about pharmaceutical drug import to Russia (June performance) here: http://rncph.com/news/17_07_2017

Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance and VAT, RUB (January 2016 – July 2017)

Share: